Riboflavin Solutions Used in Cross-Linking

Patients often hear that corneal cross-linking uses “vitamin B2 drops.” That is true, but it is only part of the story. Riboflavin is the active light-sensitive ingredient used during corneal cross-linking. However, the solution around it matters too. The carrier, thickness, osmolarity, and method of delivery can affect how well the cornea becomes saturated, how thick or thin the cornea remains during the procedure, and whether the treatment fits an epithelium-off or epithelium-on approach.

In practical terms, different riboflavin solutions are chosen for different clinical situations. Some are meant for the classic Dresden-style epithelium-off technique. Others are used when the surgeon wants less corneal thinning during soaking. Some are selected for thin corneas. Others are paired with special transepithelial or iontophoresis-assisted approaches.

What Riboflavin Does in Corneal Cross-Linking

Riboflavin acts as the photoenhancer during corneal cross-linking. After the cornea becomes adequately soaked with riboflavin, ultraviolet-A light is applied. This combination helps create additional chemical bonds between collagen fibers in the corneal stroma, which is why the procedure is called “cross-linking.” The goal is to strengthen a weakened cornea, especially in conditions such as progressive keratoconus or post-refractive ectasia.

Riboflavin also plays a protective role. It helps absorb part of the UVA energy so that deeper eye structures are less exposed. That is one reason surgeons pay close attention to corneal thickness, riboflavin saturation, and the exact protocol being used.

Main Riboflavin Solution Types Used in Cross-Linking

The main differences between riboflavin solutions relate to what the riboflavin is mixed with and how the cornea is expected to absorb it. In day-to-day practice, the major categories include:

• Dextran-based riboflavin solutions
• Dextran-free HPMC-based riboflavin solutions
• Hypo-osmolar riboflavin solutions for selected thin corneas
• Enhanced-delivery riboflavin solutions for transepithelial or epi-on protocols
• Riboflavin solutions used with iontophoresis-assisted protocols

Dextran-Based Riboflavin Solutions

The original and classic cross-linking protocols used 0.1% riboflavin in 20% dextran. This remains a well-known traditional formulation. In the United States, the FDA-labeled combination system includes Photrexa Viscous, a riboflavin 5’-phosphate ophthalmic solution with 20% dextran, used together with the KXL system.

Dextran-based solutions have an important practical effect: they tend to draw water out of the cornea during soaking. That can help prevent excessive swelling, but it can also lead to progressive corneal thinning during the procedure. For thick enough corneas, that may be acceptable. For borderline-thin corneas, it can become a meaningful issue.

Why surgeons still use dextran-based riboflavin

• It is historically well established
• It fits classic epithelium-off protocols
• It may help avoid excessive stromal swelling
• It is part of the U.S.-approved labeled system in some settings

Main trade-off

The major downside is corneal dehydration and thinning during soak time. That is one reason dextran-free alternatives became popular.

HPMC-Based Riboflavin Solutions

Many modern studies and clinical protocols use isotonic riboflavin suspended in hydroxypropyl methylcellulose (HPMC) rather than dextran. These dextran-free solutions are often chosen because they usually cause less corneal thinning during soaking. In some cases, the cornea may stay more stable in thickness, which can simplify treatment planning and improve comfort with accelerated or customized protocols.

In the FDA-labeled U.S. system, Photrexa is the dextran-free partner solution used together with Photrexa Viscous when specific thickness thresholds are met during treatment. In broader clinical practice outside one single labeled workflow, HPMC-based formulations are widely discussed because they help reduce the dehydration effect commonly seen with dextran-based soaking.

Why HPMC-based solutions are attractive

• They often reduce corneal thinning during the soak phase
• They can fit many modern accelerated protocols
• They are widely used in contemporary cross-linking literature
• They can be helpful when the surgeon wants more stable corneal thickness during treatment

Hypo-Osmolar Riboflavin for Thin Corneas

Thin corneas are a special challenge in cross-linking because the endothelium and deeper structures need adequate protection from UVA energy. In selected corneas that are too thin for a standard protocol, hypo-osmolar riboflavin may be used to swell the cornea before UVA irradiation. EyeWiki describes this as a method to increase corneal thickness to at least 400 µm before treatment in selected cases.

This does not mean every thin cornea automatically qualifies for cross-linking. It means the surgeon may use a swelling strategy as part of a more cautious plan. The final decision still depends on the actual thickness pattern, the disease severity, the protocol, and the surgeon’s judgment.

When hypo-osmolar riboflavin is discussed

• Corneas that are below the usual safety threshold
• Progressive keratoconus where treatment is still desired
• Cases where the surgeon wants to increase stromal thickness before UVA exposure

Solutions for Epi-On and Transepithelial Cross-Linking

Riboflavin is a hydrophilic molecule, which means it does not pass easily through an intact corneal epithelium. That is the key challenge of transepithelial or epi-on cross-linking. Because of this barrier, special enhanced-delivery formulations have been developed. These may include chemical enhancers or modified formulations designed to loosen tight junctions or improve stromal penetration.

In practical terms, epi-on riboflavin solutions are different from standard epi-off soaking solutions because they are trying to do a harder job: get enough riboflavin into the stroma without first removing the epithelial barrier. Some studies show promise, but the penetration challenge is one reason epi-on protocols remain an area of active refinement and debate.

Why this matters to patients

Epi-on treatment may sound gentler because the surface is not fully removed, but the chemistry and delivery become more demanding. A gentler surface experience does not automatically guarantee the same depth of riboflavin penetration or the same biological effect in every case.

Iontophoresis-Assisted Riboflavin Delivery

Iontophoresis is another way to help riboflavin enter the cornea, especially in transepithelial protocols. A mild electrical current is used to enhance delivery of riboflavin through the corneal surface. This approach tries to improve stromal loading while avoiding full epithelial removal. It is one of the better-known strategies for overcoming the penetration barrier of epi-on treatment.

For patients, the main takeaway is simple: not all cross-linking soak times or riboflavin drops are the same. Some are designed for direct surface access after epithelial removal. Others need chemical or electrical assistance to get through the intact epithelium.

How Surgeons Choose the Riboflavin Solution

Surgeons usually choose the riboflavin formulation based on the full treatment plan, not on a single preference. Important factors include:

• Whether the protocol is epi-off or epi-on
• Whether the cornea is thick enough for a standard approach
• Whether the surgeon wants to minimize intraoperative thinning
• Whether the protocol is standard Dresden or accelerated
• Whether iontophoresis is being used
• Whether the treatment follows a specific labeled device-drug workflow

What Patients Should Ask

• Will my cross-linking be epi-off or epi-on?
• Is my cornea thick enough for the standard protocol?
• Are you using a dextran-based, HPMC-based, or thin-cornea swelling approach?
• Will the riboflavin solution affect how long the soaking stage takes?
• Does my treatment follow a standard FDA-labeled protocol or another evidence-based protocol?
• How does my corneal thickness influence the riboflavin choice?

Why the “Best” Riboflavin Solution Depends on the Case

Patients naturally want to know which solution is best. The honest answer is that the best solution is the one that matches the right protocol for the right cornea. A thick cornea undergoing classic epi-off cross-linking may do well with one formulation. A thin cornea may need a swelling strategy. An epi-on case may need an enhanced-delivery or iontophoresis-assisted approach. The solution is only one part of a larger treatment design.

FAQ

1) Is riboflavin in cross-linking just vitamin B2 drops?

Riboflavin is vitamin B2, but in cross-linking it is used as a carefully prepared ophthalmic solution designed to work with UVA light and a specific treatment protocol.

2) What is the difference between dextran-based and HPMC-based riboflavin?

Dextran-based solutions are the classic traditional type and may cause more corneal thinning during soaking. HPMC-based dextran-free solutions are often used to reduce that dehydration effect.

3) Why would a surgeon use hypo-osmolar riboflavin?

Hypo-osmolar riboflavin may be used in selected thin-corneas cases to swell the cornea before UVA treatment so the procedure can be performed more safely.

4) Why is epi-on cross-linking harder from a drug-delivery standpoint?

The intact epithelium blocks riboflavin from entering the corneal stroma easily, so enhanced formulations or iontophoresis may be needed.

5) What are Photrexa and Photrexa Viscous?

They are U.S. FDA-labeled riboflavin ophthalmic solutions used with the KXL system for corneal cross-linking. One contains dextran and the other is dextran-free.

6) Can I choose the riboflavin solution myself?

Usually the surgeon chooses it based on your corneal thickness, treatment protocol, device workflow, and safety needs. It is still reasonable to ask what solution is being used and why.

Back to Top ↑